Guinness-owner Diageo posts 28% decline in profit following 'challenging' year
In its preliminary results for its 2025 financial year ending on June 30, Diageo reported net sales of $20.2bn (€17.45bn) - down 0.1% compared to the previous year - with the company citing unfavourable foreign exchange as well as acquisition and disposal adjustments.
The company's operating profit fell to $4.3bn - down 27.8%. It said this was primarily due to exceptional impairment and restructuring costs, unfavourable foreign exchange and a decline in organic operating margin.
In January, the company also raised prices on pints of Guinness as well as its other brands marking the fourth price hike in two years.
Diageo's net cash flow from operating activities increased by $200m to $4.3bn. Its net debt as of the end of June was $21.9bn.
The company recommended a full-year dividend of $1.03 per share.
Interim chief executive of Diageo Nik Jhangiani said the fiscal year had been "challenging" but the results were 'in line with our guidance'.
'While we are encouraged by areas of progress and the standout performance from Don Julio, Guinness and Crown Royal Blackberry, there is clearly much more to do across our broader portfolio and brands,' he said.
'We are also committed to strengthening our balance sheet and expect to deliver around $3bn free cash flow in fiscal 26, increasing financial flexibility whilst continuing to invest for longer term growth.'
In terms of its outlook for the current financial year, the company said it is focused on driving productivity and meeting its cost savings target which has increased from $500m to $625m.
'In fiscal 26, expect organic sales growth to be similar to fiscal 25 and organic operating profit growth to be mid-single-digit, including the impact of tariffs as at this time,' the company said.
However, the company will now have to contend with the new tariff regime implemented by US president Donald Trump which could impact sales in one of its biggest markets.
Despite the economic uncertainty, and the mounting pressure on consumers, Mr Jhangiani said he 'believe in the attractive long-term fundamentals of our industry and in our ability to continue to outperform' the rest of the industry.
'We are focused on what we can manage and control and executing at pace. The Board and management are committed to delivering improved financial performance and stronger shareholder returns on a sustained basis.'
There has been turmoil at Diageo in recent weeks following the shock departure last month of its chief executive Debra Crew after a bruising run in which the company's stock has plummeted.
Her tenure has been punctuated by setbacks including a drop in sales on cooling demand in China and the US, and a profit warning after being caught out by piles of unsold inventory in Mexico and Brazil.
The company was forced to scrap its long-held medium-term sales target in February as a result of higher trade friction denting consumer confidence.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Independent
2 hours ago
- Irish Independent
Irish brewer founded by Smithwick's family becomes second to shift operations stateside to escape Trump tariffs
An Irish beer brand revived by Smithwick's has moved most of its brewing to the US in response to the 15pc tariff President Donald Trump has put on EU imports The decision by Sullivan's Brewing Company, a Kilkenny beer brand co-founded by Dan and Alan Smithwick in 2016, comes as big pharmaceutical and technology companies seek to woo Trump by announcing largescale investments in the US. Earlier this month Apple struck a deal with Trump to invest $600bn (€515bn) in the US over the next four years to foster an 'end-to-end' American chip supply chain.
Irish Independent
2 hours ago
- Irish Independent
Pharma companies warned Government over competitiveness before Trump's tariff war began
Multinationals criticised the impact of EU rules on how they do business Major pharmaceutical companies raised concerns about Ireland's competitiveness, ahead of Donald Trump's opening shots in early April which began the tariff war with the EU. Correspondence released under the Freedom of Information Act to the Sunday Independent show that companies called on the Government to address supply chain issues and ensure there was a diverse and skilled workforce here. They also criticised the impact of EU regulations on how they do business. The warnings from Eli Lilly and Johnson & Johnson came before Mr Trump heightened uncertainty in the sector by announcing sweeping global trade tariffs, and underlined the need for Ireland to react if it is to retain its significant foreign direct investment from the pharma sector. Multinational pharmaceutical companies play a significant role in Ireland's economy. IDA Ireland data shows more than 90 pharmaceutical companies are based here and provide in the region of 45,000 jobs. They also pay billions in corporation tax. US-headquartered Eli Lilly, which employs 3,500 people in Limerick, Cork and on a nationwide commercial team, met with Department of Enterprise officials in February and outlined their concerns around the future of the EU-US trading relationship. Meanwhile, Johnson & Johnson told Enterprise Minister Peter Burke that policy enhancements for business, health and housing 'should be considered in a co-ordinated manner that reflects national strategic priorities'. Trump has threatened future tariffs of between 150pc and 250p on pharma Notes from the Eli Lilly meeting show it told Department of Enterprise and IDA Ireland officials that it wants to see 'greater intensity from Ireland at EU level, specifically around the EU pharmaceutical legislation.' New EU pharma rules, which may be adopted by the end of this year, are designed to address issues around the availability of medicines, how they are produced, and aim to improve competitiveness in the sector. But some businesses raised concerns about the protections for clinical data before it is made available to the manufacturers of cheaper generic versions of drugs. Existing rules allow pharma companies to keep clinical data for eight years. Reforms would reduce this period to six years, although extensions may apply in some scenarios. Officials here said they recognised the need to strike a balance between access to affordable medicines and incentivising innovation. Notes from the Eli Lilly meeting show officials in the Department of Enterprise acknowledged EU-US trade concerns in the pharma sector, saying 'predictability is key for business' and that European engagement would be 'bolstered by expertise from industry'. The company 'also highlighted the importance of de-risking supply chains, ensuring there is a diverse skillset in Irish operations' and said that it 'would like to see more regulation co-operation between the US and EU, especially with the US Food and Drug Administration,' meeting notes stated. A letter sent to Mr Burke by Michaela Hagenhofer, Johnson & Johnson's general manager of commercial operations in Ireland, raised concerns about the European Commission proposing 'to weaken intellectual property incentives for pharmaceuticals… from eight years to six'. The letter stated: 'At European level, it is important that Ireland secures and strengthens its reputation as a life sciences hub by advocating for a competitive business environment. In recent decades, Europe's share of pharmaceutical investment has significantly declined.' A Department of Enterprise spokesman said it supports protecting intellectual property 'and will continue to make the case for this at EU level'. The EU and US last month agreed a 15pc tariff rate would apply on most European goods imported to America. Pharmaceutical goods are not currently the subject of this tariff, but the US is examining its drug supply chains, and levies could be imposed once that analysis concludes. European Commission president Ursula von der Leyen has said any future pharma tariffs would be capped at 15pc. Trump indicated this cap may only be maintained for 'one year, one-and-a-half years maximum' and threatened future rates of between 150pc and 250pc unless pharma companies return production to the US. 'The department welcomes an agreement that will provide much needed certainty to businesses which operate in Ireland and will continue to engage with the Department of Foreign Affairs and the European Commission,' a Department of Enterprise spokesman said. 'The Department has favoured a zero-for-zero arrangement and will continue to argue against any tariffs which may interfere with the closely integrated nature of the Irish and US pharmaceutical sectors.'
Irish Examiner
a day ago
- Irish Examiner
EU braces for wave of Chinese imports as Trump tariffs redirect Shein and Temu sales
With US president Donald Trump pushing to reshape global trade with the imposition of tariffs on foreign products, firms around the world are looking to diversify into different markets while moving away from the US — which cannot be relied upon as a trusted trading partner. For China, the US has been its largest trading partner and as a result, has been the focus of Mr Trump's ire ever since he was sworn back into office. In recent years, the US has become a huge market for low cost products from the likes of online retailers Shein and Temu — who may be seeking alternative destinations for their products given difficult trading conditions with the US. However, both of these companies have been heavily criticised for numerous issues ranging from poor treatment of workers at factories, to producing low quality and environmentally damaging products, as well as products which are unsafe. Alacoque McAlpine, Irish Research Council Government of Ireland scholar at Sutherland School of Law in University College Dublin, who has for years lectured in sustainable supply chain management, said companies like Shein would be considered 'ultra fast fashion' — as they are on another level compared to retailers here such as Penneys, Zara, and H&M to name a few. 'They're not as good quality either. So they're not durable, they don't last, and they're essentially going to landfill,' she said. While the tensions between China and the US may have reduced in recent months, Chinese goods are still subject to a 30% tariff when they arrive in the US. The US is also set to end the de minimis exemption on August 29, which allowed goods valued at $800 (€682) or less to enter the country without any tariffs. Given all these trade barriers with the US, Chinese exporters may turn their eyes towards the EU — where trade relations are less volatile. China is the EU's second largest trading partner for goods after the US. During 2024, the EU imported €519bn worth of goods from China, the vast majority of which were manufactured goods. In a recent analysis, the European Central Bank (ECB) said the trade barriers now in place between the US and China may result in Chinese exports being redirected to the eurozone. It said in 2018, following Mr Trump's imposition of tariffs on China during his first term, this redirection of goods to Europe was 'significant' with the eurozone 'absorbing the trade displaced by US tariffs'. 'Between 2018 and 2019, eurozone imports from China increased by around 2 to 3%,' the analysis said. The ECB said there were several factors that suggest the eurozone could experience a larger redirection of Chinese exports. 'The composition of Chinese exports to the United States and to the eurozone is similar, making the eurozone a natural alternative,' the ECB said. 'Established supply chain links, which have expanded since the last China-US trade war, and ongoing industrial upgrades in China, facilitate the redirection of trade flows. Many euro area firms already rely on Chinese imports, making it easier to absorb redirected goods.' It also pointed out that Chinese businesses have already laid the groundwork for faster market entry into the EU, having 'almost tripled their presence with investments in European sales and distribution networks since 2017'. 'In addition, Chinese authorities have pledged targeted support to help affected exporters redirect sales to domestic or third markets, which could allow for further price cuts,' the ECB said. A crane picks a container from a truck at the Manila North Harbour Port in Manila, Philippines on Thursday, Aug. 7, 2025. (AP Photo/Aaron Favila) The bank added that increasing exports from China to the eurozone has the potential to exert downward pressure on eurozone inflation through lower import prices. In its upper estimates, the ECB suggests these tariffs could increase imports from China by 10%. While most products that make it to the EU are just made in China by large international companies, the growth of Chinese brands beyond the country's borders is becoming more common. Companies like Shein and Temu are getting a stronger foothold in the EU. Getting an idea of Shein's growing popularity can be difficult as it is a privately-owned company. According to Bloomberg News, during the first quarter of this year, the overall Shein Group reportedly generated global revenue of $10bn, with net income rising to over $400m. This was before Mr Trump implemented tariffs on Chinese imports. The Bloomberg report cited unnamed sources from the company but Shein disputed these figures without elaborating. The clothing retailer, founded in mainland China but headquartered in Singapore, does not disclose its financial figures so it is unclear how Shein fared in the second quarter after tariffs were implemented. Financial documents from Shein's Irish arm Infinite Styles Ecommerce, which handles the company's operations across the EU, show it is having considerable success in the EU. In 2023, the company reported revenue of €7.68bn — up from €4.58bn the year prior. This resulted in profit of just under €100m — up from €45.8m the year before. Also, Shein's sales in Britain, while not being in the EU, has also grown significantly — with the company reporting a 32.3% increase in revenue during its most recent financial year to £2.05bn (€2.374bn). The growth of Shein is being seen as a concern as their low cost products and business practices have been heavily criticised in the past. President Donald Trump speaks to reporters aboard Air Force One while en route to meet with Russia's President Vladimir Putin at Joint Base Elmendorf-Richardson, Alaska, Friday, Aug. 15, 2025. (AP Photo/Julia Demaree Nikhinson) Ms McAlpine said all the 'slick marketing' from companies like Shein has made 'consumers think that they need to buy the products more frequently, and they kind of treat them as disposable'. 'There is rapid turnover of new products again on a weekly basis. It's mainly polyester based, so there's a huge environmental impact there,' she said. 'Fast fashion has always had a very negative impact on the environment. In the last 20 years, global fibre production has doubled, and it's expected to grow if things continue the way they are. The fashion industry is the second biggest consumer of water industry-wide, it's responsible for 10% of global carbon emissions.' Ms McAlpine said all these textiles are going to the dump because they cannot be recycled, due to being plastic based or mixed fibres. She said: 'Shein is selling a lot of products, and they're selling it very cheaply. How do they do this? Well, they do it by putting a lot of pressure on their suppliers at the end of the supply chain, and then those suppliers put pressure on their workers.' She also said that the growing prevalence of Shein also means that retailers here will also try to stay competitive and as prices fall, it will ultimately hurt the worker who makes the product. 'Prices keep falling, and then the garment factories have to respond to the price pressure, and they will cut the most flexible cost, which is wages,' she said. Ms McAlpine said she doesn't blame the consumer, this is an 'extremely profitable industry' and these companies encourage people to be buying and disposing of their clothes on a regular basis. She said: 'I just don't believe consumers woke up in the morning and decided to spend all our money on this. I believe it's the marketing by the companies that have convinced us. They kind of changed our perception of fashion, and they're really good at making us feel bad about ourselves so we buy more.' Ms McAlpine said there are no international standards in regards to regulating these supply chains and there are no health and safety regulations these firms have to follow when sourcing their products. 'I think regulation is important. All the companies went overseas to take advantage of low-cost wages and lax environmental standards and with no commensurate regulation,' she said, adding that these companies eventually got in trouble for issues such as child labour, not paying workers, and environmental issues. She said some companies tried to impose codes of conduct but this hasn't worked: 'I think we cannot leave it up to the companies. Unfortunately, we need legislation, and the EU has been putting in place legislation, but unfortunately, since the Draghi report last September, they're all about cutting the red tape, and they're deregulating everything.' In a statement, Shein said they operate a 'customer-driven, on-demand business model' that allows the company to meet demand 'while reducing overproduction and waste and maintaining affordability at the same time'. In regards to its supply chain conditions, it said it is committed to 'fostering a safe and fair work environment for all of our suppliers' employees'. The company added that it invests time and money into ensuring workers in its supply chain are 'treated fairly', while working with third-party agencies to monitor compliance with local laws and international standards. Temu, on the other hand, has its own problems. Its owner, PDD Holdings, reported a 47% drop in profit during its first quarter of the year amid local competition and global trade uncertainty. Whaleco Technology Limited is the Irish arm of PDD Holdings for the purpose of doing business in the EU. In its latest available financial documents, from 2023, it generated just under €758m in revenue from its operations, resulting in a profit of €38m. Last month, EU justice commissioner Michael McGrath said he was shocked at the toxicity and dangers of some goods being sold to Temu and Shein amid a crackdown on the retail platforms. Among the worst examples cited by Mr McGrath include baby soothers with beads that fall off easily, which pose a choking hazard because they did not have the regulation size hole to enable a baby who did swallow one accidentally to continue to get air. Other goods cited by MEPs include children's raincoats with toxic chemicals, sunglasses with no UV filter, and kids shorts with draw strings longer than regulation length that cause a trip hazard. There were also concerns about certain banned chemicals in cosmetics. EU figures show 12m low-value items coming into the bloc a day, amounting to 4.6bn during 2024 valued at under €150 — double that of 2023 and three times as many as 2022. In an attempt to combat these low value products surging into the bloc, the EU is considering whether to close its own de minimis exemption, set at €150. They're good at making us feel bad about ourselves so we buy more
